ArticleJAMA network open2024

Use of SGLT2 Inhibitors vs GLP-1 RAs and Anemia in Patients With Diabetes and CKD.

Jia-Chian Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.